Pixels & Pills

Entries Tagged as 'marketing'

Where Are the Pharma Superbowl Ads?

February 6th, 2012 · 1 Comment · Opinion

By Sven Larsen (@svenplarsen)
Watching the big game last night,  I was struck by the diversity of products being advertised. Domain name registration and e-trading as well as the old reliables like packaged goods and automobiles. But one category was conspicuous by it’s absence. Where were the Pharma Superbowl ads?
It’s not like big Pharma companies don’t [...]

Share

[Read more →]

Tags:·····

What Pharma Could Learn from Mad Men

January 20th, 2012 · 1 Comment · Opinion

by Jason Brandt (@jasondmg3)
Mad Men protagonist Don Draper works in the show’s fictional advertising agency, but the challenges he faces are real, and not much different than what many healthcare marketers face on a daily basis – meeting deadlines, incorporating new technologies, managing perceptions, and influencing behaviors all while ensuring personal growth.
The pharmaceutical industry and [...]

Share

[Read more →]

Tags:···········

Lean Digital Strategy

January 19th, 2012 · No Comments · Opinion, Trends

by Jason Brandt (@jasondmg3)
Can two of the hottest organizational and operational trends from the last 20 years – Lean Manufacturing and Six Sigma – be adapted to pharma? That’s a trick question: They already have been, and quite successfully.
But, how about online pharma marketing? It’s a more interesting proposition.
First, some definitions for the majority of [...]

Share

[Read more →]

Tags:···········

Making the Case for Mobile in Healthcare

January 18th, 2012 · 1 Comment · Trends

We’ve been writing a lot about the case for mobile in healthcare over the past couple of years. And we’re going to keep writing about it. With one quarter of US adults turning to their mobiles for healthcare information, it’s important that the industry keeps pushing forward with innovative sites, apps and tools that will [...]

Share

[Read more →]

Tags:············

Conversation: Darshan Kulkarni on the FDA Draft Guidance

January 17th, 2012 · No Comments · News, Opinion

Last week Pixels & Pills’ editor Briana Campbell had the pleasure of sitting down for a Skype chat (so the quality is a little lower than our normal, professional videos) with Dr. Darshan Kulkarni (@FDALawyers) of the Kulkarni Law Firm in Philadelphia. And while the questions answered in the conversation don’t constitute legal advice and [...]

Share

[Read more →]

Tags:···············

Richman’s Dear Jonathan Letter

January 13th, 2012 · 1 Comment · News

By DJ Edgerton (@wiltonbound)
Who’d have thought we would see the day?
Charlie Sheen leaving TWO AND A HALF MEN. Demi leaving Ashton. Kim Kardashian leaving Kris Humphries (ok that one, I did see coming). Oprah leaving her own show. And now Jonathan Richman leaving the Pharma industry. What’s the world coming to?
I’m not just trying [...]

Share

[Read more →]

Tags:······

Why Aren’t We Talking About H-Commerce?

January 12th, 2012 · 2 Comments · Knowledge, Opinion, Trends

By Sven Larsen
These days everyone is familiar with e-commerce. And our more social media savvy readers are probably all clued up on f-commerce (that’s Facebook commerce folks). I’ve even heard Google’s Adwords and Adsense business referred to as g-commerce. But what about the next letter in the alphabet. How come no one is talking about [...]

Share

[Read more →]

Tags:·············

Have You Evolved?

January 4th, 2012 · No Comments · News, Trends

We recently chatted with Paul Simms, Chairman of eyeforpharma, the mastermind behind the ‘Pharmasuiticus reps’ YouTube nature “documentary,” which you may have seen doing the rounds in your social networks.
Pixels&Pills: Why did you decide to make this video?
Paul Simms: We find ourselves quite frustrated with the current situation in pharmaceutical sales management. This is still [...]

Share

[Read more →]

Tags:···············

Can Pharma Harness Social Media for Product Research and Development?

January 2nd, 2012 · No Comments · Knowledge, Opinion

by DJ Edgerton (@wiltonbound)
The question seems almost nonsensical at first – your Twitter followers may be really outstanding people, but they’re not organic chemists or researchers. And your Facebook fans, while devoted, probably do not, generally speaking, know how to move a new drug through the FDA approval process.
Just the same, it’s a mistake to [...]

Share

[Read more →]

Tags:·····················

Year In Review: Ceci Zak of Sanofi at Digital Pharma East

December 29th, 2011 · No Comments · Knowledge

Ceci Zak of Sanofi speaks to Alice An at Digital Pharma East, after her presentation on the focus on consumer-centric marketing in pharma.
What direction do you think this will take in 2012?

Share

[Read more →]

Tags:······